2021
DOI: 10.3390/toxics9020025
|View full text |Cite
|
Sign up to set email alerts
|

Benzodiazepines: Their Use either as Essential Medicines or as Toxics Substances

Abstract: This review highlights the nature, characteristics, properties, pharmacological differences between different types of benzodiazepines, the mechanism of action in the central nervous system, and the degradation of benzodiazepines. In the end, the efforts to reduce the benzodiazepines’ adverse effects are shown and a reflection is made on the responsible uses of these medications.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
17
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(22 citation statements)
references
References 88 publications
(107 reference statements)
0
17
0
Order By: Relevance
“…Anxiety and depression affect about 300 million (4.4 percent) and 264 million (3.6 percent) people of the world’s population, respectively, according to a World Health Organization 2015 report [ 5 ], and they have been two of the most prevalent forms of disease globally for several years [ 20 ]. In accordance with the concern of their rising prevalence, the side effects observed and confirmed for the prolonged use of conventional drugs has been a major dilemma for the authorities that approve such medication with very serious side effects, and also for the patient that has to accept being exposed to those side effects with no other alternative [ 7 ]. All those facts combined have stepped up the hunt for other safe and affordable alternative therapies [ 21 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Anxiety and depression affect about 300 million (4.4 percent) and 264 million (3.6 percent) people of the world’s population, respectively, according to a World Health Organization 2015 report [ 5 ], and they have been two of the most prevalent forms of disease globally for several years [ 20 ]. In accordance with the concern of their rising prevalence, the side effects observed and confirmed for the prolonged use of conventional drugs has been a major dilemma for the authorities that approve such medication with very serious side effects, and also for the patient that has to accept being exposed to those side effects with no other alternative [ 7 ]. All those facts combined have stepped up the hunt for other safe and affordable alternative therapies [ 21 ].…”
Section: Discussionmentioning
confidence: 99%
“…Depression and anxiety treatments only act in the long term. They are fraught with side effects, such as orthostatic hypotension, tachycardia, digestive disorders, weight gain, sexual disorders, or even visual disorders, and one major problem that comes after more prolonged exposure is memory impairment [ 7 , 8 ]. It has been declared that long-time use of benzodiazepines affects memory [ 9 ].…”
Section: Introductionmentioning
confidence: 99%
“…The majority of BZD prescriptions (92.6%) are anxiolytics (N05B), whereas only a small percentage of 7.4% are hypnotic or sedative BZD (N05CD), which reveals a prescribing preference for anxiolytic BZD rather than for the sedative or hypnotic ones [ 17 , 32 , 33 , 34 ]. This predisposition may possibly be related to the strong sedative effect caused by N05CD-BZD, which ultimately leads to a prescribing preference towards slightly less soporific BZD, such as anxiolytics, assuring a milder effect in the central nervous system (CNS) [ 35 ]. Furthermore, the predominance of anxiety, depression, stress, loneliness, and mild insomnia—mental health issues commonly and advisedly treated with anxiolytics—in Portuguese older adults, could also contribute to this prescribing tendency [ 4 , 36 , 37 , 38 , 39 , 40 ].…”
Section: Discussionmentioning
confidence: 99%
“…130 A certain number of benzodiazepines have been clinically deployed as anxiolytic agents, namely, triflubazam, razobazam, and clobazam (Scheme 13). 131 Because of their significant medicinal applications, Shaabani and coworkers designed and prepared AuCu as well as bimetallic nanoparticles of AgCu anchored on guanidine-attached reduced graphene oxide (rGO) nanosheets and investigated their catalytic activity for the preparation of benzodiazepine derivatives through a tandem reductive/MCRs strategy. 132 Au or Ag nanoparticle catalysts were found to be remarkable contenders for the reduction of nitro functionalities due to their proficiency in the catalytic hydrogenation of nitro derivatives into anilines by NaBH 4 .…”
Section: ■ Gold Np-catalyzed Mcrsmentioning
confidence: 99%